[1]张洪磊,郝伟,张婷△.养心益阳汤对慢性心力衰竭患者IL-6、IL-18、hs-CRP水平的影响[J].西部中医药,2020,33(08):86-88.[doi:10.12174/j.issn.1004-6852.2020.08.22]
　ZHANG Honglei,HAO Wei,ZHANG Ting.Influence of Heart-nourishing Yang-invigorating Decoction on the Levels of IL-6,IL-18 and hs-CRP in CHF Patients[J].Western Journal of Traditional Chinese Medicine,2020,33(08):86-88.[doi:10.12174/j.issn.1004-6852.2020.08.22]
点击复制

养心益阳汤对慢性心力衰竭患者IL-6、IL-18、hs-CRP水平的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年08期
页码:
86-88
栏目:
出版日期:
2020-08-15

文章信息/Info

Title:
Influence of Heart-nourishing Yang-invigorating Decoction on the Levels of IL-6,IL-18 and hs-CRP in CHF Patients
文章编号:
1004-6852(2020)08-0086-03
作者:
张洪磊1，郝伟2，张婷1△
1 杨凌示范区医院，陕西 西安 712100； 2 西安市中医医院
Author(s):
ZHANG Honglei1, HAO Wei2, ZHANG Ting1△
1 Yangling Demonstration Zone Hospital, Xi′an 712100, China; 2 Xi′an Hospital of Traditional Chinese Medicine
关键词:
慢性心力衰竭; 养心益阳汤; 美托洛尔; 心肺功能; 炎症因子
Keywords:
heart-nourishing yang-invigorating decoction;  chronic heart failure;  metaprolol; cardiac and pulmonary function;  inflammatory factors
分类号:
R714.252
DOI:
10.12174/j.issn.1004-6852.2020.08.22
文献标志码:
B
摘要:
目的：观察养心益阳汤治疗慢性心力衰竭的临床疗效及对患者白细胞介素6(interleukin-6，IL-6)、白细胞介素18(interleukin-18，IL-18)、超敏C反应蛋白(high-sensitivity C-reactive protein，hs-CRP)水平的影响。方法：将95例患者按入院顺序分为两组。对照组48例，给予利尿剂、强心苷、血管扩张剂等常规西医治疗，同时给予美托洛尔进行治疗；观察组47例，在对照组治疗基础上服用养心益阳汤，两组均治疗3个月。对比两组临床疗效、心肺功能指标和炎症因子水平。结果：总有效率观察组为89.4%(42/47)，对照组为60.4%(29/48)，两组比较差异有统计学意义(P＜0.05)。用力肺活量（forced vital capacity,FVC)、一秒钟用力呼气容积(first second forced vital capacity,FEV1)、左心室射血分数(left ventricular ejection fraction，LVEF)、脑尿钠肽(brain natriuretic peptide，BNP)水平治疗前两组比较，差异无统计学意义(P＞0.05),两组治疗后FVC、FEV1、左室EF值两组均显著升高(P＜0.05)，BNP水平两组均明显降低(P＜0.05)，且观察组更为显著(P＜0.05)。IL-6、IL-18、hs-CRP水平治疗前两组比较，差异无统计学意义(P＞0.05)；治疗后两组均显著降低(P＜0.05)，且观察组降低更为显著(P＜0.05)。结论：养心益阳汤治疗慢性心力衰竭临床疗效显著，其可有效改善患者的心肺功能指标，并调节其炎症因子水平。
Abstract:
Objective: To observe clinical effects of heart-nourishing yang-invigorating decoction (HY) in the treatment for chronic heart failure (CHF) and its influence on the levels of IL-6, IL-18 and hs-CRP. Methods: All 95 patients were allocated to two groups according to admission order. 48 cases of the control group were given Western medicine therapy including diuretics, cardiac glycoside, vasodilator and others, meanwhile, metoprolol; 47 cases of the observation group took HY, both groups were treated for three months. To compare clinical effects, the indexes of cardiac and pulmonary function and the levels of inflammatory factors. Results: Total effective rate of the observation group reached 89.4% (42/47), higher than 60.4% (29/48) of the control group, and the difference showed statistical meaning between both groups (P＜0.05). There was no obvious difference in the levels of FVC, FEV1, LVEF and BNP between both groups before treating (P＞0.05); after treating, FVC, FEV1 and LVEF of both groups rose (P＜0.05), BNP level lowered notably in both groups (P＜0.05), and the improvements of the observation group were more notable (P＜0.05). There was no obvious difference in the levels of IL-6, IL-18 and hs-CRP before treating between both groups (P＞0.05); after treating these reduced notably in both groups (P＜0.05), the decrease of the observation group was more notable (P＜0.05). Conclusion: Heart-nourishing yang-invigorating decoction in the treatment for CHF could gain notable clinical effects, and it could effectively improve the indexes of cardiac and pulmonary function, and regulate the levels of inflammatory factors.

相似文献/References:

[1]李清秀,陈守强△.从运气学说探讨乙未年慢性心力衰竭的诊治规律[J].西部中医药,2015,28(10):84.
[2]刘世梅,胡 琰,杜景柏,等.以心功能分级为依据的中医分型治疗慢性心力衰竭临床观察[J].西部中医药,2018,31(09):97.
　LIU Shimei,HU Yan,DU Jingbai,et al.Clinical Observation on Treating Chronic Congestive Heart Failure by TCM Pattern Treatment on the Foundation of Cardiac Functional Grading[J].Western Journal of Traditional Chinese Medicine,2018,31(08):97.
[3]刘明晖,赵树华△.五苓散治疗慢性心力衰竭60例[J].西部中医药,2017,30(02):74.
　LIU Minghui,ZHAO Shuhua.WuLing San in Treating 60 Cases of Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2017,30(08):74.
[4]李亮,姬艳苏△.黄芪总皂苷对心力衰竭大鼠JAK2和STAT3的影响[J].西部中医药,2018,31(09):17.
　LI Liang,JI Yansu.Effects of Total Saponins of HuangQi on JAK2/STAT3 of the Rats with Heart Failure[J].Western Journal of Traditional Chinese Medicine,2018,31(08):17.
[5]孙小静,张亚峰.参附注射液治疗慢性心力衰竭疗效观察[J].西部中医药,2019,32(05):84.
　SUN Xiaojing,ZHANG Yafeng.Clinical Observation on ShenFu Injection in the Treatment for Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2019,32(08):84.
[6]赵丽娴,袁天慧,陈汉裕.冼绍祥教授从“双心”角度论治慢性心力衰竭思想荟萃[J].西部中医药,2020,33(05):38.[doi:10.12174/j.issn.1004-6852.2020.05.11]
　ZHAO Lixian,YUAN Tianhui,et al.Professor Xian Shaoxiang′s Thinking of Treating Chronic Heart Failure Based on the Angle of ″Two Hearts″[J].Western Journal of Traditional Chinese Medicine,2020,33(08):38.[doi:10.12174/j.issn.1004-6852.2020.05.11]
[7]刘颖,李争,张玉焕,等.芪参益气汤联合厄贝沙坦治疗老年慢性心力衰竭临床观察[J].西部中医药,2020,33(06):98.[doi:10.12174/j.issn.1004-6852.2020.06.26]
　LIU Ying,LI Zheng,ZHANG Yuhuan,et al.Clinical observation on Qishen Yiqi Tang and Irbesartan in Treating Senile Patients with Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2020,33(08):98.[doi:10.12174/j.issn.1004-6852.2020.06.26]
[8]李星星,李岩,范宗静,等.慢性心力衰竭合并焦虑抑郁的研究进展[J].西部中医药,2021,34(07):150.[doi:10.12174/j.issn.2096-9600.2021.07.38]
　LI Xingxing,LI Yan,FAN Zongjing,et al.Research Progress of Chronic Heart Failure with Anxiety and Depression[J].Western Journal of Traditional Chinese Medicine,2021,34(08):150.[doi:10.12174/j.issn.2096-9600.2021.07.38]
[9]冯思颖,吴威妮,褚庆民,等.基于网络药理学探讨葶苈大枣泻肺汤治疗慢性心力衰竭的作用机制[J].西部中医药,2021,34(05):26.[doi:10.12174/j.issn.2096-9600.2021.05.07]
　FENG Siying,WU Weini,CHU Qingmin,et al.The Mechanism of Tingli Dazao Xiefei Tang in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(08):26.[doi:10.12174/j.issn.2096-9600.2021.05.07]
[10]寿鑫甜,王禹萌,李学思,等.从辨证复杂性论慢性心力衰竭[J].西部中医药,2021,34(05):140.[doi:10.12174/j.issn.2096-9600.2021.05.36]
　SHOU Xintian,WANG Yumeng,LI Xuesi,et al.On Chronic Heart Failure from the Complexity of Syndrome Differentiation[J].Western Journal of Traditional Chinese Medicine,2021,34(08):140.[doi:10.12174/j.issn.2096-9600.2021.05.36]

备注/Memo

备注/Memo:
收稿日期：2019-08-07作者简介：张洪磊(1984—)，男，硕士学位，主治医师。研究方向：心血管内科疾病的中西医结合诊治。△通讯作者：张婷(1983—)，女，硕士学位，主治医师。研究方向：中医抗衰老及老年病的临床研究。
更新日期/Last Update: 2020-08-15